on 10 Jan 2025
Last Applicant/ Owned by
Novartis AG
CH-4002 Basel
CH
Serial Number
2281086 filed on 27th Jul 2023
Registration Number
TMA1283506 registered on 10th Jan 2025
Registration expiry Date
17th Mar 2028Trademark usage description
préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les m Read More9
2281086
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 20th Sept 2024 | Search Recorded |
Submitted for opposition 256 on 15th Jul 2024 | Notification of Possible Opposition Sent |
Submitted for opposition 210 on 11th Jul 2024 | IR Correction |
Submitted for opposition 257 on 11th Jul 2024 | Designation Notification - Madrid Protocol |
Submitted for opposition 257 on 14th Sept 2023 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 13th Sept 2023 | Created |
Submitted for opposition 31 on 13th Sept 2023 | Formalized |
Submitted for opposition 30 on 27th Jul 2023 | Filed |
Submitted for opposition 238 on 17th Mar 2018 | IR Renewed |
Submitted for opposition 228 on 17th Mar 2008 | International Registration |